TYSABRI Lifts Biogen (BIIB) to Q4 Beat; FY12 Outlook is Muted

Go back to TYSABRI Lifts Biogen (BIIB) to Q4 Beat; FY12 Outlook is Muted
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 202.95 -4.98 (2.4%)
Previous Close $207.93    52 Week High $333.65 
Open $207.51    52 Week Low $223.02 
Day High $208.05    P/E 25.99 
Day Low $202.57    EPS $7.81 
Volume 1,062,259